GELECTRIC MEDICAL

Our company specializes in an innovative electrically adhesive gel patch that securely adheres to tissue surfaces, enabling targeted treatment where standard sutures fail. Harnessing the phenomena of electroadhesion, this groundbreaking technology has the potential to transform tissue repair.

TRANSFORMING SURGICAL TECHNIQUES

Gelectric Medical's approach is simple yet revolutionary. Our adhesive gel patch securely bonds to tissue surfaces via application of an electric field, enabling precise treatment in areas where traditional sutures may not suffice. The adhesive properties can be easily reversed by altering the polarity of the electrical field.

FOUNDERS

Leah Klein Borden, Ph.D

Leah, a pioneering researcher in biomaterials, is redefining the field with her groundbreaking work. Her first-authored paper in Nature Communications reveals the discovery of reversible tissue adhesion using hydrogels. Recognized with numerous prestigious awards, Leah is a trailblazer in biomaterial research. She regularly presents at academic conferences, sharing her insights and driving cross-disciplinary collaborations that fuel transformative advancements.


Matthew Dowling, Ph.D

Matt is an accomplished innovator and founder with a background in bioengineering and chemical engineering. He co-created Medcura, an innovative biomaterials platform, and has led Medcura to secure $6 million in grants. Under his leadership, the company achieved 5 FDA clearances, filed 8 patents, and published numerous high-impact papers. Matt's groundbreaking work has been featured in international media outlets, solidifying his reputation as an industry trailblazer.


James Borden, Ph.D

James has a proven track record in startups, expertise in biophysics, and mastery of biotech software development. With a deep understanding of the intricacies of both the business and scientific realms, James possesses a remarkable ability to bridge the gap between the two. His experience and sharp entrepreneurial mindset drive success in every venture.


ADVISORS

Lou Lieto, Ph.D

Dr. Lou Lieto is a Partner in the patents and innovations practice at Wilson Sonsini Goodrich & Rosati. Lou focuses on patent prosecution, licensing, strategic patent counseling, mergers & acquisitions, capital markets, global generics, and IP due diligence in a variety of fields, including biologics, pharmaceuticals,nutraceuticals, clean energy, diagnostics, embryonic stem cells, medical devices, transgenic animals, and gene therapy. Lou received his J.D. from the George Washington University Law School and his Ph.D. from the University of Kentucky.


Srinivasa R. Raghavan, Ph.D

Dr. Srinivasa Raghavan is a Scientific Collaborator wtih Gelectric. He is Full Professor in the Department of Chemical and Biomolecular Engineering at UMD. He is the principal investigator of the Complex Fluids and Nanomaterials Laboratory. He has authored over 100 technical papers in peer reviewed journals and is a recipient of a 2004 NSF Career Award for his work in self-assembled stimuli-responsive nanomaterials. He was the winner of the 2010 E. Robert Kent Outstanding Teaching Award from the Clark School of Engineering at UMD.


Mayur Narayan, MD, MBA

Dr. Mayur Narayan is Chair of Surgery at RJW Barnabas Health in New Brunswick, NJ. He is a high-volume anastomosis surgeon, and is considered a clinical thought leader in the space. He has authored over 50 technical papers in peer reviewed journals, with over 500 citations and was one of the pioneers in the development of the fibrin sealant bandage during his time as a US Army doctor. Mayur is also an MBA with Board Advisement experience at innovative, established medical device companies, such as Z-Medica and Medcura.


Tricia Kontoudis

Tricia has worked in medical devices (both Class II and Class III), regulatory affairs, and manufacturing for more than 15 years. She was at MCRA, which is one of the top medical device regulatory advisement firms in the US. Patricia routinely assists clients in the preparation of regulatory submissions, including premarket notifications, premarket approval applications, investigational device exemption submissions, investigational new drug applications, and biologics license applications. She also assists in the review of validation protocols, standard operating procedures, QSR compliance documentation, supplier audits, and facility audits.


  • Regulatory Advisor